The protocol needs amendments:
The protocol needs amendments:
1- The researcher explained that the study will start in July 2024.
2- The principal investigator wrote that the protocol had not been reviewed.
3- The researcher did not explain how to obtain human liver cells (HEPG-2), colon cancer cells (CACO-2), and lung cancer cells (A549).
4- The Median lethal dose (LD50) study needs clarification because the number of mice that will be used is more than what the principal researcher indicated.
5- There is still repetition in many parts of the protocol.
6- In the form of good care of animals used in research, the researcher must list the handling of animals only (in vivo) and not the cells in the laboratory (in vitro).